JPRN-UMIN000011462
Recruiting
未知
The clinical study of the budesonide/formoterol combination drug additional dosage in the perioperative period in a lung cancer patient with COPD. - The clinical study of the budesonide/formoterol combination drug additional dosage in the perioperative period in a lung cancer patient with COPD.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer patients with COPD.
- Sponsor
- Hamamatsu University School of Medicine
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patient that there is ICS/LABA mixing medicine in pre\-administering within four weeks 2\)Patient where exacerbation of COPD was admitted within four weeks 3\)Patient that there is past of hypersensitivity in atropine, the kind edge material or tiotropium, budesonide or formoterol 4\)Patient who has chronic ailments of lungs, heart, kidney, liver, and blood, etc. 5\)Patient who has previous history of adrenal cortical insufficiency or accentuation syndrome 6\)Patient who has glaucoma 7\)Patient who has dysuria such as dysuria by enlarged prostate 8\)Case who judged doctor in charge targets and it is improper
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Study on the effects of the budesonide/formoterol combination formulation in improving airway inflammation and airway resistance in patients with bronchial asthmaPatients with bronchial asthma aged 20 years and older (males and females, outpatients and inpatients) being treated with an ICS (at a dose equivalent to FP 200-1000 mcg/day) and salmeterol 100 mcg/day in combination (either as two separate products or one combined product) for 3 months or longer with poor or inadequate controlJPRN-UMIN000006572Chiba-Hokusoh Hospital, Nippon Medical School80
Completed
Not Applicable
Clinical effects of budesonide/formoterol in patients with asthmaBronchial asthmaJPRN-UMIN000003745Atami Hospital International University of Health and Welfare30
Completed
Not Applicable
Effects of budesonide and formoterol combination on airway regulatory T cells in mild asthmaticsJPRN-UMIN000004275Division of respirology, neurology, and rheumatology, Department of medicine, Kurume University School of Medicine10
Completed
Not Applicable
Improved effects of Budesonide/Formoterol combination therapy (Symbicort) on the residual eosinophilic inflammation in the distal airways of asthmatic patients who used the salmeterol/fluticasone combination drugBronchial asthmaJPRN-UMIN000003805JA Tohno Kousei Hospital40
Recruiting
Not Applicable
Clinical efficacy in the budesonide / folmoterol for the COPD patients under using tiotropium.COPDJPRN-UMIN000011449Komaki City Hospital20